html5-img
1 / 40

INFORMED CONSENT

INFORMED CONSENT. Dr. I. Manorama Thomas B.Sc. (Hons.), MBBS; M.S; F.A.M.S. Emeritus Professor, St. Johns Medical College, Chairperson Independent Ethics Committee, Bangalore. Why Informed Consent ?. Research Done The Wrong Way – I The Tuskeegee Syphilis Study *.

carina
Télécharger la présentation

INFORMED CONSENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. INFORMED CONSENT Dr. I. Manorama Thomas B.Sc. (Hons.), MBBS; M.S; F.A.M.S. Emeritus Professor, St. Johns Medical College, Chairperson Independent Ethics Committee, Bangalore

  2. Why Informed Consent ?

  3. Research Done The Wrong Way – IThe Tuskeegee Syphilis Study * • Longest non-therapeutic experiment on human beings in medical history: The progress of untreated syphilis (1932-72). • 399 poor African-American sharecroppers in rural Macon County, Alabama, USA. • The men were told they were being treated for “bad blood”. • Even after penicillin was discovered and found to be a miracle cure, the men were not treated or even told what they had. • US government officials went to extreme lengths to insure that they received no therapy from any source. • Presidential apology, May 1997 * Tuskegee Syphilis Study Legacy Committee Final Report of May 20, 1996

  4. Research Done The Wrong Way – IINazi Prisoner Research During World War II • Objectives of various trials: • Effect of cold, heat, chemicals on men, women and children • “Time to death” testing in response to stressors in healthy “volunteers” • Organ transplant experiments on healthy “volunteers” • Any information given (some?) is irrelevant because prisoners were forced to participate • Outcome: • 23 German scientists taken to court, 7 acquitted, 9 imprisoned, 7 given death sentence • Nuremberg Code of 1947

  5. Informed Consent in Human ResearchThe Origins • Before the 20th century, guidelines required physician’s need to adhere to acceptable medical standards • Issue of patient’s agreement to the research never discussed • Most requirements arose after the Nuremberg trials

  6. Informed Consent in Human ResearchThe Origins • Emerges from the ethical principle of Respect for Persons • Individuals be treated as capable of taking decisions for themselves (“autonomy”) • Those with diminished autonomy be protected

  7. What is informed consent? • Informed consent is a PROCESS • Involves • Providing all relevant information to the volunteer/ patient • The patient/ volunteer understanding the information provided • Voluntarily agreeing to participate • A basic right

  8. Biomedical Research in HumansGuidelines for Informed Consent • The Nuremberg Code, 1947 • The Declaration of Helsinki, 1964 (2000) • The Belmont Report, 1979 • ICH GCP, 1997 • ICMR Guidelines, 2000

  9. The Nuremberg CodeWhat is it? • A set of 10 principles on research involving humans • Developed after the horrors of Nazi experiments on humans became public • Published in 1947

  10. The Nuremberg Code and Informed Consent • The voluntary consent of the human subject is absolutely essential • Person must have legal capacity to consent • Should have “sufficient knowledge and comprehension” to make an “understanding and enlightened decision” • Must be able to exercise “free power of choice”

  11. The Nuremberg Code and Informed Consent • Inform the subject of • The nature, duration and purpose • The method and means • All inconveniences and hazards • Possible effects on health • There should be no force, fraud, deceit, duress, coercion

  12. The Declaration of Helsinki What is it? • A statement of ethical principles on research involving humans • Published by the World Medical Association • Developed from the Nuremberg Code • Made by physicians • First adopted at Helsinki in 1964

  13. The Declaration of Helsinki andInformed Consent • Subjects must be • Volunteers • Informed participants • Consent be obtained, preferably in writing • If subject in a dependent relationship with the physician, consent be obtained by an independent physician

  14. The Declaration of Helsinki andInformed Consent • Consent from legally acceptable representative required if subject: • Minor • Incapable of giving consent • Physical or mental disability • If subject is a minor, assent be taken, where possible

  15. The Declaration of Helsinki andInformed Consent • When consent not possible prior to participation in research • Approved by the “review committee” • Consent must be obtained as soon as possible from the subject or a legally acceptable representative

  16. The Belmont ReportWhat is it? • Ethical principles and guidelines for protecting humans in clinical research • Developed by a commission set up in the US in the aftermath of the Tuskeegee Study becoming public • Published in 1979

  17. The Belmont Report and Informed Consent • Identifies three elements of the process • Information • Comprehension • Voluntariness

  18. The Belmont Report and Informed Consent • Information • All information be provided • Conditions under which information provided also important (rapid/ disorganized manner?) • Comprehension • Adapt presentation of information to subject’s capacities • Investigators must ascertain comprehension • Special provisions – immaturity, mental disability • Voluntariness • There must be no coercion or undue influence

  19. ICMR GuidelinesWhat are they? • Ethical guidelines for research involving humans • “Ethical Guidelines for Biomedical Research on Human Subjects” • Published by the Indian Council of Medical Research in 2000

  20. ICMR Guidelines and Informed Consent • Participation must be voluntary • Participants must be “fully apprised of the research” • The investigator must obtain informed consent • Responsibilities and information that must be provided • Assent be obtained, where possible, for minors • Requirement for consent can be waived by an ethics committee if risk is minimal (e.g. collecting data from subjects’ records)

  21. Summary • Guidelines require • All relevant information be provided to subjects • Ascertaining they understand what their participation means for them • Voluntary consent • Protecting vulnerable subjects with additional safeguards

  22. Informed Consent Various terms • Patient Information Sheet • Provides only the information • Informed Consent Form • Used to document consent • Both integrated in to one document called the informed consent form

  23. WHAT IS INFORMED CONSENT ? • Informed consent is … “consent given by a • competent individual who • has received the necessary information • has adequately understood the information • after considering the information, has arrived • at a decision without having been subjected • to coercion, undue influence or inducement, • or intimidation”. • CIOMS International Ethical Guidelines

  24. INFORMED CONSENT AS A PROCESS • Informed consent is a communication process : • between the researcher and the participant • starts before the research is initiated • continues throughout the duration of the study FHI, Research Ethics Training Curriculum

  25. Information in informed consent • Provided in writing • The informed consent form • Discussed with the subject • Consent must be in a language the subject understands

  26. Counseling • Who does the counseling.? • Clinical Investigator—Preferably a senior who has experience or at least trained in counseling .

  27. PROCESS OF INFORMED CONSENT Timing Before screening Nature of research project • Explicitly state that it is research • How subjects will be recruited • Purpose / aim of research • Investigators’ names & affiliations

  28. What must a subject know?Treatments • Trial treatment(s) • Treatments • Investigational product and placebo • Investigational product and active comparator • Investigational product in different doses • Probability for random assignment of treatments • “flipping a coin”/ “drawing a card” • What chance that the subject would be assigned to a particular treatment • “equal chance”

  29. Study procedures • What is subject’s involvement • Duration of study • Explain about sample collections (not just names • of tests) • Procedures which are research / experimental • If treatment, how different from conventional • Randomization / blinding • No. of subjects in study

  30. Potential risks : Benefits • Medical, social, psychological, economic • Probability, magnitude Participation • Voluntary • Can withdraw • No penalty, no loss of benefits No coercion No statement / information that causes subject / subject’s legally acceptable representative to waive any legal rights or release investigator / sponsor /institution from liability for negligence Circumstances for termination of subject’s participation by investigator

  31. Any questions, further information whom to ask rights of research subject, AEs Language • Clear, simple, non technical • Sufficient time to make decision • Give written information • Translations written / verbal • Thumb impressions allowed • All signatures should be dated ljy, Li”V

  32. Confidentiality, privacy adverse consequences of information eg. psychiatric illness, sexual preferences, substance abuse, to employers, insurance, legal authorities, HIV stigma Monitor / auditor/IRB/IEC/ regulatory authority have direct access to records without violating confidentiality to extent permitted & subject authorizes such access by signing consent Publication, identity will remain confidential

  33. WAIVER OF INFORMED CONSENT • Minimal risk • Rights and welfare of participants protected • Research not possible without a waiver • Appropriate information provided FHI, Research Ethics Training Curriculum

  34. SUMMARY-INFORMED CONSENT • Moral, not just legal requirement • Comprehensibility essential • Cultural influences • Support information helpful • Pre-testing • Free of coercion

  35. Format of informed consent form for subjects participating in clinical trial • Study Title: • Study Number : • Subject Initials :___________ Subject’s Name :____________ • Date of births / age ________ • Please initial • box (Subject) • I confirm that I have read and understood the information sheet date [ ] • for the above study and have had the opportunity to ask questions • I understand that my participation in the study is voluntary and that I [ ] • am free to withdraw at any time, without giving any reason, without my • medical care or legal rights being affected. • I understand that the Sponsor of the clinical trial, others working on the [ ] • Sponsor’s behalf, the Ethics Committee and the regulatory authorities will • not need my permission to look at my health records both in respects of • the current study and any further research that may be conducted in relation • to it, even if I withdraw from the trial. I agree to this access. However, I • understand that my identity will not be revealed in any information • released to third parties or published.

  36. 4. I agree not to restrict the use of any data or results that arise from this study [ ] provided such a use is only for scientific purpose(s) 5. I agree to take part in the above study [ ] Signature (or Thumb impression) of the Subject/Legally acceptable Representative :_______________ Date : Signatory’s Name Signature of the Investigator : Date Study Investigator’s Name Signature of the witness Date

  37. Resource Material • 1. Ethical guidelines for Biomedical Research on Human • Subjects, Indian Council of Medical Research (ICMR) • New Delhi 2000 • 2. The Gazette of India Extraordinary Part II Section 3(I) • Research Ethics Training Curriculum R.Rivera, • D. Borasky, R. Rice, Family Health International, 2001. • http://www.fhi.org • Designing Clinical Research An Epidemiologic Approach • Ed Stephen, B Hulley, Steven R. Cummings Williams & • Wilkins, Batlimore

  38. Our Experience • What IEC/IRBs should look for: • Inspect facility in C.R.Os/ Hospitals/otherplaces, especially, Space, ICU facilities, No. of beds, whether bunker beds, Food-Hygiene ,Recreation &Toilet Facilities. • DCGI permission.

  39. Insurance Dosage of drugs, expiry dates of drugs. Compensation amount. ICF Different languages. ADVERSE EVENTS . Diet Our Experience contd

  40. Thank you

More Related